Skypeptides represent a remarkably novel class of therapeutics, engineered by strategically combining short peptide sequences with unique structural motifs. These clever constructs, often mimicking the secondary structures of larger proteins, are demonstrating immense potential for targeting a broad spectrum of diseases. Unlike traditional peptide

VIP peptide is recognized as a intriguing therapeutic target for a variety of diseases. This neuropeptide exhibits significant effects on the central nervous system, influencing activities including pain perception, inflammation, and gastrointestinal motility. Research suggests that VIP peptide has potential in treating conditions like inflammatory